West Pharmaceutical Services (NYSE:WST) touted results today from a study showing that its ID Adapter can improve the intradermal administration of polio vaccines.
The study, published in the journal Vaccine, evaluated the feasibility of using a fractional inactivated polio virus vaccine in remote locations where polio outbreaks continue to be of serious concern to public health officials.
Get the full story at our sister site, Drug Delivery Business News.
The post Study: West’s device aids in dose-sparing administration of polio vaccine appeared first on MassDevice.